Head to Head Survey: Pharma Bio Serv (PBSV) and Wilhelmina International (WHLM)

Pharma Bio Serv (OTCMKTS:PBSV) and Wilhelmina International (NASDAQ:WHLM) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability and analyst recommendations.


This table compares Pharma Bio Serv and Wilhelmina International’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Pharma Bio Serv 7.07% 7.61% 6.11%
Wilhelmina International 1.28% 1.05% 0.63%


Pharma Bio Serv pays an annual dividend of $0.08 per share and has a dividend yield of 7.6%. Wilhelmina International does not pay a dividend.

Institutional & Insider Ownership

5.0% of Wilhelmina International shares are owned by institutional investors. 51.6% of Pharma Bio Serv shares are owned by insiders. Comparatively, 64.8% of Wilhelmina International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Pharma Bio Serv and Wilhelmina International, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pharma Bio Serv 0 0 0 0 N/A
Wilhelmina International 0 0 0 0 N/A

Earnings & Valuation

This table compares Pharma Bio Serv and Wilhelmina International’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pharma Bio Serv $17.79 million 1.38 $1.27 million N/A N/A
Wilhelmina International $73.20 million 0.40 $160,000.00 N/A N/A

Pharma Bio Serv has higher earnings, but lower revenue than Wilhelmina International.

Risk and Volatility

Pharma Bio Serv has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500. Comparatively, Wilhelmina International has a beta of 0.4, meaning that its share price is 60% less volatile than the S&P 500.


Pharma Bio Serv beats Wilhelmina International on 6 of the 10 factors compared between the two stocks.

About Pharma Bio Serv

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm the United States, Europe, and Brazil markets. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

About Wilhelmina International

Wilhelmina International, Inc. provides fashion model and talent management services. The company engages in the representation and management of models, entertainers, artists, athletes, and other talent to various clients. It offers fashion modeling and social media influencer services to clients, such as advertising agencies, branded consumer goods companies, fashion designers, magazine publications, retailers, department stores, product catalogs, and Internet sites. The company also represents artists in the hair, makeup, photography, and stylist arenas to various companies in the media, advertising, retail, pharmaceutical, and music industries. In addition, it is involved in the licensing of the Wilhelmina name to third-parties, such as fashion model agencies; and television syndication royalties and production series contracts; and celebrity management activities. The company has operations in Los Angeles, Miami, London, Chicago, the United States, and internationally. Wilhelmina International, Inc. was founded in 1967 and is headquartered in Dallas, Texas.

Receive News & Ratings for Pharma Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.